Figure 2.
Cumulative bleeding incidences. Cumulative incidence of CRB and MB in the full study cohort (n = 791, A-B), in patients without anticoagulation (n = 671, C-D), and patients with anticoagulation at study inclusion (n = 120, E-F).

Cumulative bleeding incidences. Cumulative incidence of CRB and MB in the full study cohort (n = 791, A-B), in patients without anticoagulation (n = 671, C-D), and patients with anticoagulation at study inclusion (n = 120, E-F).

or Create an Account

Close Modal
Close Modal